Inhaled epoprostenol vs inhaled nitric oxide for refractory hypoxemia in critically ill patients.

[1]  J. Wetterslev,et al.  Inhaled Nitric Oxide for Acute Respiratory Distress Syndrome and Acute Lung Injury in Adults and Children: A Systematic Review with Meta-Analysis and Trial Sequential Analysis , 2011, Anesthesia and analgesia.

[2]  M. Buckley,et al.  Inhaled Epoprostenol for the Treatment of Pulmonary Arterial Hypertension in Critically Ill Adults , 2010, Pharmacotherapy.

[3]  R. Shemin,et al.  A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients. , 2009, The Journal of thoracic and cardiovascular surgery.

[4]  T. Evans,et al.  Inhaled nitric oxide therapy in adults. , 2005, The New England journal of medicine.

[5]  B. Erstad,et al.  Retrospective Evaluation of Inhaled Prostaglandins in Patients with Acute Respiratory Distress Syndrome , 2005, Pharmacotherapy.

[6]  G. Angelini,et al.  Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right-heart dysfunction, and refractory hypoxemia after cardiothoracic surgery. , 2004, The Journal of thoracic and cardiovascular surgery.

[7]  Brian K Walsh,et al.  Inhaled prostacyclin for the treatment of pulmonary hypertension after cardiac surgery , 2002, Critical care medicine.

[8]  J. T. Cope,et al.  Aerosolized prostacyclin (epoprostenol) as an alternative to inhaled nitric oxide for patients with reperfusion injury after lung transplantation. , 2001, The Journal of thoracic and cardiovascular surgery.

[9]  T. de Giacomo,et al.  Hemodynamic and oxygenation changes of combined therapy with inhaled nitric oxide and inhaled aerosolized prostacyclin. , 2001, Journal of cardiothoracic and vascular anesthesia.

[10]  S. Ricksten,et al.  Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. , 1998, Chest.

[11]  M. Booke,et al.  Inhaled Prostaglandin E1 for Treatment of Acute Lung Injury in Severe Multiple Organ Failure , 1998, Anesthesia and analgesia.

[12]  M. Haller,et al.  Inhaled prostacyclin (PGI2) versus inhaled nitric oxide in adult respiratory distress syndrome. , 1996, American journal of respiratory and critical care medicine.

[13]  P. V. van Heerden,et al.  Inhaled Aerosolized Prostacyclin and Nitric Oxide as Selective Pulmonary Vasodilators in ARDS—A Pilot Study , 1996, Anaesthesia and intensive care.

[14]  W. Seeger,et al.  Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome. , 1996, American journal of respiratory and critical care medicine.

[15]  S. Turner,et al.  Cost Implications of Using Inhaled Nitric Oxide Compared with Epoprostenol for Pulmonary Hypertension , 1995, The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians.

[16]  R. Rossaint,et al.  Inhaled nitric oxide for the adult respiratory distress syndrome. , 1993, The New England journal of medicine.